Omics Technologies Improving Breast Cancer Research and Diagnostics

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699 · see citing works

Hallmarks of Cancer: The Next Generation

Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590 · see citing works

PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer

Hartkopf, A. D., Taran, F., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,989 · see citing works

Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2

Bolyen, E., Rideout, J. R., Dillon, M. R., Bokulich, N. A., Abnet, C. C., Al-Ghalith, G. A., Alexander, H., Alm, E. J., Arumugam, M., Asnicar, F., et al. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0209-9 · Cited by 23,742 · see citing works

QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies

Whiting, P. F., Rutjes, A. W. S., Westwood, M. E., Mallett, S., Deeks, J. J., Reitsma, J. B., Leeflang, M. M. G., Sterne, J. A. C., Bossuyt, P. M. M., & the QUADAS-2 Group* (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-8-201110180-00009 · Cited by 14,199 · see citing works

Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer

Nishimura, R., Osako, T., Nishiyama, Y., Tashima, R., Nakano, M., Fujisue, M., Toyozumi, Y., & Arima, N. (2013) · Oncology · doi:10.1159/000353099 · Cited by 13,239 · see citing works

Comprehensive molecular portraits of human breast tumours

The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129 · see citing works

Gene expression profiling predicts clinical outcome of breast cancer

van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536 · see citing works

Microenvironmental regulation of tumor progression and metastasis

Quail, D. F., & Joyce, J. A. (2013) · Nature Medicine · doi:10.1038/nm.3394 · Cited by 7,994 · see citing works

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies

Lehmann, B. D., Bauer, J. A., Chen, X., Sanders, M. E., Chakravarthy, A. B., Shyr, Y., & Pietenpol, J. A. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45014 · Cited by 5,592 · see citing works

Triple-Negative Breast Cancer

Foulkes, W. D., Smith, I. E., & Reis-Filho, J. S. (2010) · New England Journal of Medicine · doi:10.1056/nejmra1001389 · Cited by 4,719 · see citing works

Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses

Mogensen, T. H. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00046-08 · Cited by 3,122 · see citing works

Metabolomics: beyond biomarkers and towards mechanisms

Johnson, C. H., Ivanisevic, J., & Siuzdak, G. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.25 · Cited by 2,829 · see citing works

Detection and localization of surgically resectable cancers with a multi-analyte blood test

Cohen, J. D., Li, L., Wang, Y., Thoburn, C., Afsari, B., Danilova, L., Douville, C., Javed, A. A., Wong, F., Mattox, A., et al. (2018) · Science · doi:10.1126/science.aar3247 · Cited by 2,783 · see citing works

Alpelisib for <i>PIK3CA</i> -Mutated, Hormone Receptor–Positive Advanced Breast Cancer

André, F., Ciruelos, E., Rubovszky, G., Campone, M., Loibl, S., Rugo, H. S., Iwata, H., Conte, P., Mayer, I. A., Kaufman, B., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1813904 · Cited by 2,622 · see citing works

Single-Cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment

Azizi, E., Carr, A. J., Plitas, G., Cornish, A. E., Konopacki, C., Prabhakaran, S., Nainys, J., Wu, K., Kiseliovas, V., Setty, M., et al. (2018) · Cell · doi:10.1016/j.cell.2018.05.060 · Cited by 1,976 · see citing works

Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial

Cristofanilli, M., Turner, N. C., Bondarenko, I., Ro, J., Im, S.-A., Masuda, N., Colleoni, M., DeMichele, A., Loi, S., Verma, S., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00613-0 · Cited by 1,827 · see citing works

A single-cell and spatially resolved atlas of human breast cancers

Wu, S. Z., Al-Eryani, G., Roden, D. L., Junankar, S., Harvey, K., Andersson, A., Thennavan, A., Wang, C., Torpy, J. R., Bartonicek, N., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00911-1 · Cited by 1,775 · see citing works

Development and Validation of a Radiomics Nomogram for Preoperative Prediction of Lymph Node Metastasis in Colorectal Cancer

Huang, Y., Liang, C., He, L., Tian, J., Liang, C., Chen, X., Ma, Z., & Liu, Z. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.65.9128 · Cited by 1,745 · see citing works

Ten years of next-generation sequencing technology

van Dijk, E., Auger, H., Jaszczyszyn, Y., & Thermes, C. (2014) · Trends in Genetics · doi:10.1016/j.tig.2014.07.001 · Cited by 1,632 · see citing works

Widespread Shortening of 3′UTRs by Alternative Cleavage and Polyadenylation Activates Oncogenes in Cancer Cells

Mayr, C., & Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.06.016 · Cited by 1,613 · see citing works

Effect of Three Decades of Screening Mammography on Breast-Cancer Incidence

Bleyer, A., & Welch, H. G. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1206809 · Cited by 1,371 · see citing works

Metabolomics for Investigating Physiological and Pathophysiological Processes

Wishart, D. S. (2019) · Physiological Reviews · doi:10.1152/physrev.00035.2018 · Cited by 1,247 · see citing works

Chemoresistance Evolution in Triple-Negative Breast Cancer Delineated by Single-Cell Sequencing

Kim, C. R., Gao, R., Sei, E., Brandt, R., Hartman, J., Hatschek, T., Crosetto, N., Foukakis, T., & Navin, N. E. (2018) · Cell · doi:10.1016/j.cell.2018.03.041 · Cited by 1,091 · see citing works

Circulating Tumor Cells at Each Follow-up Time Point during Therapy of Metastatic Breast Cancer Patients Predict Progression-Free and Overall Survival

Hayes, D. F., Cristofanilli, M., Budd, G. T., Ellis, M. J., Stopeck, A., Miller, M. C., Matera, J., Allard, W. J., Doyle, G. V., & Terstappen, L. W. M. M. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2821 · Cited by 1,032 · see citing works

Single-cell RNA-seq enables comprehensive tumour and immune cell profiling in primary breast cancer

Chung, W., Eum, H. H., Lee, H.-O., Lee, K.-M., Lee, H.-B., Kim, K.-T., Ryu, H. S., Kim, S., Lee, J. E., Park, Y. H., et al. (2017) · Nature Communications · doi:10.1038/ncomms15081 · Cited by 992 · cited 1× · see citing works

Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis

Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab), Savas, P., Virassamy, B., Ye, C., Salim, A., Mintoff, C. P., Caramia, F., Salgado, R., Byrne, D. J., Teo, Z. L., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0078-7 · Cited by 992 · see citing works

Liquid Biopsy: From Discovery to Clinical Application

Alix‐Panabières, C., & Pantel, K. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1311 · Cited by 983 · see citing works

The single-cell pathology landscape of breast cancer

Jackson, H. W., Fischer, J. R., Zanotelli, V. R., Ali, H. R., Mechera, R., Soysal, S. D., Moch, H., Muenst, S. E., Varga, Z., Weber, W. P., et al. (2020) · Nature · doi:10.1038/s41586-019-1876-x · Cited by 891 · see citing works

Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data

Bidard, F., Peeters, D. J. E., Fehm, T. N., Nolè, F., Gisbert‐Criado, R., Mavroudis, D., Grisanti, S., Generali, D., García-Sáenz, J. Á., Stebbing, J., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70069-5 · Cited by 842 · see citing works

Integration of 3D digital mammography with tomosynthesis for population breast-cancer screening (STORM): a prospective comparison study

Ciatto, S., Houssami, N., Bernardi, D., Caumo, F., Pellegrini, M., Brunelli, S., Tuttobene, P., Bricolo, P., Fantò, C., Valentini, M., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70134-7 · Cited by 838 · see citing works

Spatially and functionally distinct subclasses of breast cancer-associated fibroblasts revealed by single cell RNA sequencing

Bartoschek, M., Oskolkov, N., Bocci, M., Lövrot, J., Larsson, C., Sommarin, M., Madsen, C. D., Lindgren, D., Pekar, G., Karlsson, G., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07582-3 · Cited by 826 · see citing works

Metabolomics in cancer research and emerging applications in clinical oncology

Schmidt, D. R., Patel, R., Kirsch, D. G., Lewis, C. A., Heiden, M. G. V., & Locasale, J. W. (2021) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21670 · Cited by 652 · see citing works

Circulating Tumor Cells and Response to Chemotherapy in Metastatic Breast Cancer: SWOG S0500

Smerage, J. B., Barlow, W. E., Hortobágyi, G. N., Winer, E. P., Leyland-Jones, B. R., Srkalović, G., Tejwani, S., Schott, A. F., O’Rourke, M. A., Lew, D. L., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.56.2561 · Cited by 649 · see citing works

Endocrine-Therapy-Resistant ESR1 Variants Revealed by Genomic Characterization of Breast-Cancer-Derived Xenografts

Li, S., Shen, D., Shao, J., Crowder, R. J., Liu, W., Prat, A., He, X., Liu, S., Hoog, J., Lu, C., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.08.022 · Cited by 623 · see citing works

Circulating Tumor Cells Predict Survival in Early Average-to-High Risk Breast Cancer Patients

Rack, B., Schindlbeck, C., Jückstock, J., Andergassen, U., Hepp, P., Zwingers, T., Friedl, T. W. P., Lorenz, R., Tesch, H., Fasching, P. A., et al. (2014) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dju066 · Cited by 615 · see citing works

Metabolic barriers to cancer immunotherapy

DePeaux, K., & Delgoffe, G. M. (2021) · Nature reviews. Immunology · doi:10.1038/s41577-021-00541-y · Cited by 614 · see citing works

A pan-cancer proteomic perspective on The Cancer Genome Atlas

Akbani, R., Ng, P. K. S., Werner, H. M. J., Shahmoradgoli, M., Zhang, F., Ju, Z., Liu, W., Yang, J.-Y., Yoshihara, K., Li, J., et al. (2014) · Nature Communications · doi:10.1038/ncomms4887 · Cited by 600 · see citing works

Applications of single-cell sequencing in cancer research: progress and perspectives

Lei, Y., Tang, R., Xu, J., Wang, W., Zhang, B., Liu, J., Yu, X., & Shi, S. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01105-2 · Cited by 597 · see citing works

Analysis of ESR1 mutation in circulating tumor DNA demonstrates evolution during therapy for metastatic breast cancer

Schiavon, G., Hrebien, S., García-Murillas, I., Cutts, R. J., Pearson, A., Tarazona, N., Fenwick, K., Kozarewa, I., López‐Knowles, E., Ribas, R., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aac7551 · Cited by 589 · see citing works

Novel Theranostic Opportunities Offered by Characterization of Altered Membrane Lipid Metabolism in Breast Cancer Progression

Hilvo, M., Denkert, C., Lehtinen, L., Müller, B. M., Brockmöller, S. F., Seppänen‐Laakso, T., Budczies, J., Bucher, E., Yetukuri, L., Castillo, S., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3894 · Cited by 532 · see citing works

Proteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted Therapy

Krug, K., Jaehnig, E. J., Satpathy, S., Blumenberg, L. M., Karpova, A. Y., Anurag, M., Miles, G., Mertins, P., Geffen, Y., Tang, L. C., et al. (2020) · Cell · doi:10.1016/j.cell.2020.10.036 · Cited by 532 · see citing works

Circulating tumour cells in non-metastatic breast cancer: a prospective study

Lucci, A., Hall, C. S., Lodhi, A., Bhattacharyya, A., Anderson, A. E., Xiao, L., Bedrosian, I., Kuerer, H. M., & Krishnamurthy, S. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70209-7 · Cited by 507 · see citing works

Artificial intelligence-based multi-omics analysis fuels cancer precision medicine

He, X., Liu, X., Zuo, F., Shi, H., & Jing, J. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.12.009 · Cited by 474 · see citing works

MRI for breast cancer screening, diagnosis, and treatment

Morrow, M., Waters, J., & Morris, E. A. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61350-0 · Cited by 450 · see citing works

Luminal B Breast Cancer: Molecular Characterization, Clinical Management, and Future Perspectives

Ades, F., Zardavas, D., Božović‐Spasojević, I., Pugliano, L., Fumagalli, D., de Azambuja, E., Viale, G., Sotiriou, C. P., & Piccart, M. J. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.54.1870 · Cited by 441 · see citing works

Early circulating tumor DNA dynamics and clonal selection with palbociclib and fulvestrant for breast cancer

O’Leary, B., Hrebien, S., Morden, J. P., Beaney, M., Fribbens, C. V., Huang, X., Liu, Y., Bartlett, C. H., Koehler, M. T., Cristofanilli, M., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03215-x · Cited by 418 · see citing works

Spatial deconvolution of HER2-positive breast cancer delineates tumor-associated cell type interactions

Andersson, A., Larsson, L., Stenbeck, L., Salmén, F., Ehinger, A., Wu, S. Z., Al-Eryani, G., Roden, D., Swarbrick, A., Borg, Å., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26271-2 · Cited by 404 · see citing works

Somatic Mutations Drive Distinct Imaging Phenotypes in Lung Cancer

Velazquez, E. R., Parmar, C., Liu, Y., Coroller, T. P., Cruz, G., Stringfield, O., Ye, Z., Makrigiorgos, M. G., Fennessy, F., Mak, R. H., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0122 · Cited by 391 · see citing works

Pooled Analysis of the Prognostic Relevance of Circulating Tumor Cells in Primary Breast Cancer

Janni, W., Rack, B. K., Terstappen, L. W. M. M., Pierga, J., Taran, F., Fehm, T. N., Hall, C. S., de Groot, M. R., Bidard, F., Friedl, T. W. P., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1603 · Cited by 363 · see citing works

Expression and function of epithelial cell adhesion molecule EpCAM: where are we after 40 years?

Gires, O., Pan, M., Schinke, H., Canis, M., & Baeuerle, P. A. (2020) · Cancer and Metastasis Reviews · doi:10.1007/s10555-020-09898-3 · Cited by 355 · see citing works

Transcriptome profiling revealed multiple genes and ECM-receptor interaction pathways that may be associated with breast cancer

Bao, Y., Wang, L., Shi, L., Yun, F., Liu, X., Chen, Y., Chen, C., Ren, Y., & Jia, Y. (2019) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-019-0162-0 · Cited by 354 · see citing works

Comprehensive metabolomics expands precision medicine for triple-negative breast cancer

Xiao, Y., Ma, D., Yang, Y., Yang, F., Ding, J.-H., Gong, Y., Jiang, L., Ge, L., Wu, S., Yu, Q., et al. (2022) · Cell Research · doi:10.1038/s41422-022-00614-0 · Cited by 330 · see citing works

Single-cell transcriptome analysis of tumor and stromal compartments of pancreatic ductal adenocarcinoma primary tumors and metastatic lesions

Lin, W., Noel, P., Borazanci, E. H., Lee, J., Amini, A., Han, I. W., Heo, J. S., Jameson, G., Fraser, C. R., Steinbach, M. A., et al. (2020) · Genome Medicine · doi:10.1186/s13073-020-00776-9 · Cited by 328 · see citing works

Association of Breast Cancer DNA Methylation Profiles with Hormone Receptor Status and Response to Tamoxifen

Widschwendter, M., Siegmund, K. D., Müller, H. M., Fiegl, H., Marth, C., Müller‐Holzner, E., Jones, P. A., & Laird, P. W. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3852 · Cited by 322 · see citing works

Quiescent cancer cells resist T cell attack by forming an immunosuppressive niche

Baldominos, P., Barbera-Mourelle, A., Barreiro, O., Huang, Y., Wight, A. E., Cho, J.-W., Zhao, X., Estivill, G., Adam, I., Sanchez, X., et al. (2022) · Cell · doi:10.1016/j.cell.2022.03.033 · Cited by 315 · see citing works

Personalized circulating tumor DNA analysis to detect residual disease after neoadjuvant therapy in breast cancer

McDonald, B. R., Contente‐Cuomo, T., Sammut, S., Odenheimer-Bergman, A., Ernst, B. J., Perdigones, N., Chin, S., Farooq, M., Mejia, R., Cronin, P. A., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aax7392 · Cited by 306 · see citing works

Transcriptome Profiling in Human Diseases: New Advances and Perspectives

Casamassimi, A., Federico, A., Rienzo, M., Esposito, S., & Ciccodicola, A. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081652 · Cited by 288 · see citing works

Human breast microbiome correlates with prognostic features and immunological signatures in breast cancer

Tzeng, A., Sangwan, N., Jia, M. R., Liu, C.-C., Keslar, K. S., Downs-Kelly, E. P., Fairchild, R. L., Al‐Hilli, Z., Grobmyer, S. R., & Eng, C. (2021) · Genome Medicine · doi:10.1186/s13073-021-00874-2 · Cited by 279 · see citing works

Artificial intelligence system reduces false-positive findings in the interpretation of breast ultrasound exams

Shen, Y., Shamout, F. E., Oliver, J. R., Witowski, J. S., Kannan, K., Park, J., Wu, N., Huddleston, C., Wolfson, S., Millet, A., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26023-2 · Cited by 278 · see citing works

Breast cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D mammography alone (STORM-2): a population-based prospective study

Bernardi, D., Macaskill, P., Pellegrini, M., Valentini, M., Fantò, C., Ostillio, L., Tuttobene, P., Luparia, A., & Houssami, N. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30101-2 · Cited by 275 · see citing works

Integrative Methods and Practical Challenges for Single-Cell Multi-omics

Ma, A., McDermaid, A., Xu, J., Chang, Y., & Ma, Q. (2020) · Trends in biotechnology · doi:10.1016/j.tibtech.2020.02.013 · Cited by 272 · see citing works

Quantitative Multiplex Methylation-Specific PCR Assay for the Detection of Promoter Hypermethylation in Multiple Genes in Breast Cancer

Fackler, M. J., McVeigh, M., Mehrotra, J., Blum, M. A., Lange, J. R., Lapides, A., Garrett, E., Argani, P., & Sukumar, S. V. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3341 · Cited by 270 · see citing works

Single‐cell RNA sequencing in breast cancer: Understanding tumor heterogeneity and paving roads to individualized therapy

Ding, S., Chen, X., & Shen, K. (2020) · 癌症：英文版 · doi:10.1002/cac2.12078 · Cited by 267 · see citing works

Inference of transcription factor binding from cell-free DNA enables tumor subtype prediction and early detection

Ulz, P., Perakis, S. O., Zhou, Q. X., Moser, T., Belic, J., Lazzeri, I., Wölfler, A., Zebisch, A., Gerger, A., Pristauz, G., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12714-4 · Cited by 265 · see citing works

Ultrasound for Breast Cancer Detection Globally: A Systematic Review and Meta-Analysis

Sood, R., Rositch, A. F., Shakoor, D., Ambinder, E. B., Pool, K.-L., Pollack, E. B., Mollura, D. J., Mullen, L. A., & Harvey, S. C. (2019) · Journal of Global Oncology · doi:10.1200/jgo.19.00127 · Cited by 261 · see citing works

Breast Cancer Screening Using Tomosynthesis or Mammography: A Meta-analysis of Cancer Detection and Recall

Marinovich, M. L., Hunter, K. E., Macaskill, P., & Houssami, N. (2018) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djy121 · Cited by 250 · see citing works

The Crosstalk Between Tumor Cells and the Immune Microenvironment in Breast Cancer: Implications for Immunotherapy

Salemme, V., Centonze, G., Cavallo, F., Defilippi, P., & Conti, L. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.610303 · Cited by 249 · see citing works

Digital Breast Tomosynthesis: Concepts and Clinical Practice

Chong, A., Weinstein, S. P., McDonald, E. S., & Conant, E. F. (2019) · Radiology · doi:10.1148/radiol.2019180760 · Cited by 244 · see citing works

Insight into the heterogeneity of breast cancer through next-generation sequencing

Russnes, H. G., Navin, N. E., Hicks, J. B., & Børresen‐Dale, A. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57088 · Cited by 240 · see citing works

Prognostic utility of HOXB13 : IL17BR and molecular grade index in early-stage breast cancer patients from the Stockholm trial

Jerevall, P.-L., Ma, X.-J., Li, H., Salunga, R. C., Kesty, N. C., Erlander, M. G., Sgroi, D. C., Holmlund, B., Skoog, L. K., Fornander, T., et al. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.145 · Cited by 220 · see citing works

The Proteomic Landscape of Triple-Negative Breast Cancer

Lawrence, R., Perez, E. M., Hernández, D., Miller, C. P., Haas, K. M., Irie, H. Y., Lee, S., Blau, C. A., & Villén, J. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.03.050 · Cited by 219 · see citing works

Clinical and translational values of spatial transcriptomics

Zhang, L., Chen, D., Song, D., Liu, X., Zhang, Y., Xu, X., & Wang, X. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00960-w · Cited by 212 · see citing works

Atlas of breast cancer infiltrated B-lymphocytes revealed by paired single-cell RNA-sequencing and antigen receptor profiling

Hu, Q., Hong, Y., Qi, P., Lu, G., Mai, X., Xu, S., He, X., Guo, Y., Gao, L., Jing, Z., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22300-2 · Cited by 201 · see citing works

Molecular Subtyping of Triple-Negative Breast Cancers by Immunohistochemistry: Molecular Basis and Clinical Relevance

Zhao, S., Ma, D., Xiao, Y., Li, X., Ma, J., Zhang, H., Xu, X., Lv, H., Jiang, W., Yang, W.-T., et al. (2020) · The Oncologist · doi:10.1634/theoncologist.2019-0982 · Cited by 199 · see citing works

Metabolic crosstalk in the breast cancer microenvironment

Dias, A. S., Almeida, C. R., Helguero, L. A., & Duarte, I. F. (2019) · European Journal of Cancer · doi:10.1016/j.ejca.2019.09.002 · Cited by 198 · see citing works

Neratinib Efficacy and Circulating Tumor DNA Detection of <i>HER2</i> Mutations in <i>HER2</i> Nonamplified Metastatic Breast Cancer

Ma, C. X., Bose, R., Gao, F., Freedman, R. A., Telli, M. L., Kimmick, G., Winer, E., Naughton, M., Goetz, M. P., Russell, C., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0900 · Cited by 193 · see citing works

Correlation of L‐type amino acid transporter 1 and CD98 expression with triple negative breast cancer prognosis

Furuya, M., Horiguchi, J., Nakajima, H., Kanai, Y., & Oyama, T. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.02151.x · Cited by 189 · see citing works

Glucose Metabolism on Tumor Plasticity, Diagnosis, and Treatment

Lin, X., Xiao, Z., Chen, T., Liang, S. H., & Guo, H. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00317 · Cited by 176 · see citing works

BRCA1 CpG Island Hypermethylation Predicts Sensitivity to Poly(Adenosine Diphosphate)- Ribose Polymerase Inhibitors

Veeck, J., Ropero, S., Setién, F., González‐Suárez, E., Osório, A., Benitez, J. J., Herman, J. G., & Esteller, M. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.1010 · Cited by 173 · see citing works

Single-cell RNA sequencing reveals cell heterogeneity and transcriptome profile of breast cancer lymph node metastasis

Xu, K., Wang, R., Xie, H., Hu, L., Wang, C., Xu, J., Zhu, C., Liu, Y., Gao, F., Li, X., et al. (2021) · Oncogenesis · doi:10.1038/s41389-021-00355-6 · Cited by 166 · see citing works

Metabolomics: Moving to the Clinic

Nordström, A., & Lewensohn, R. (2009) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-009-9156-4 · Cited by 164 · see citing works

Correlation between CpG methylation profiles and hormone receptor status in breast cancers

Feng, W., Shen, L., Wen, S., Rosen, D. G., Jelı́nek, J., Hu, X., Huan, S., Huang, M. L., Liu, J., Şahin, A. A., et al. (2007) · Breast Cancer Research · doi:10.1186/bcr1762 · Cited by 154 · see citing works

Circulating tumor DNA and circulating tumor cells in metastatic triple negative breast cancer patients

Madic, J., Kiialainen, A., Bidard, F., Birzele, F., Ramey, G., Leroy, Q., Frio, T. R., Vaucher, I., Raynal, V., Bernard, V., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.29265 · Cited by 147 · see citing works

Overcoming Genetically Based Resistance Mechanisms to PD-1 Blockade

Torrejon, D. Y., Abril-Rodriguez, G., Champhekar, A. S., Tsoi, J., Campbell, K. M., Kalbasi, A., Parisi, G., Zaretsky, J. M., Garcia-Diaz, A., Puig-Saus, C., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-1409 · Cited by 146 · see citing works

Targeting HER2 heterogeneity in breast cancer

Hamilton, E. P., Shastry, M., Shiller, S. M., & Ren, R. (2021) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2021.102286 · Cited by 136 · see citing works

BreastMark: An Integrated Approach to Mining Publicly Available Transcriptomic Datasets Relating to Breast Cancer Outcome

Madden, S. F., Clarke, C., Gaule, P., Aherne, S. T., O’Donovan, N., CLYNES, M. M., Crown, J. P., & Gallagher, W. M. (2013) · Breast Cancer Research · doi:10.1186/bcr3444 · Cited by 133 · see citing works

Prospective analysis of circulating metabolites and breast cancer in EPIC

His, M., Viallon, V., Dossus, L., Gicquiau, A., Achaintre, D., Scalbert, A., Ferrari, P., Romieu, I., Onland‐Moret, N. C., Weiderpass, E., et al. (2019) · BMC Medicine · doi:10.1186/s12916-019-1408-4 · Cited by 130 · see citing works

Multivariate Modeling and Prediction of Breast Cancer Prognostic Factors Using MR Metabolomics

Giskeødegård, G. F., Grinde, M. T., Sitter, B., Axelson, D. E., Lundgren, S., Fjøsne, H. E., Dahl, S., Gribbestad, I. S., & Bathen, T. F. (2009) · Journal of Proteome Research · doi:10.1021/pr9008783 · Cited by 128 · see citing works

Proteomic analysis of archival breast cancer clinical specimens identifies biological subtypes with distinct survival outcomes

Asleh, K., Negri, G. L., Miko, S. E. S., Colborne, S., Hughes, C. S., Wang, X. Q., Gao, D., Gilks, C. B., Chia, S., Nielsen, T. O., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28524-0 · Cited by 127 · see citing works

Histone H3 lysine 4 acetylation and methylation dynamics define breast cancer subtypes

Messier, T., Gordon, J. A. R., Boyd, J. R., Tye, C. E., Browne, G., Stein, J. L., Lian, J. B., & Stein, G. S. (2016) · Oncotarget · doi:10.18632/oncotarget.6922 · Cited by 125 · see citing works

Liquid Biopsy in Breast Cancer: A Focused Review

Tay, T. K. Y., & Tan, P. H. (2020) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2019-0559-ra · Cited by 119 · see citing works

Circulating cell-free DNA-based epigenetic assay can detect early breast cancer

Uehiro, N., Sato, F., Pu, F., Tanaka, S., Kawashima, M., Kawaguchi, K., Sugimoto, M., Saji, S., & Toi, M. (2016) · Breast Cancer Research · doi:10.1186/s13058-016-0788-z · Cited by 117 · see citing works

Spatial Transcriptomic Analysis of a Diverse Patient Cohort Reveals a Conserved Architecture in Triple-Negative Breast Cancer

Bassiouni, R., Idowu, M. O., Gibbs, L. D., Robila, V., Grizzard, P. J., Webb, M. G., Song, J., Noriega, A., Craig, D. W., & Carpten, J. D. (2022) · Cancer Research · doi:10.1158/0008-5472.can-22-2682 · Cited by 114 · see citing works

Overview of Artificial Intelligence in Breast Cancer Medical Imaging

Zheng, D., He, X., & Jing, J. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12020419 · Cited by 113 · see citing works

Clinical Performance of Synthesized Two-dimensional Mammography Combined with Tomosynthesis in a Large Screening Population

Aujero, M., Gavenonis, S. C., Benjamin, R., Zhang, Z., & Holt, J. (2017) · Radiology · doi:10.1148/radiol.2017162674 · Cited by 113 · see citing works

Quantification of Free Circulating Tumor DNA as a Diagnostic Marker for Breast Cancer

Catarino, R., Ferreira, M. M. F., Rodrigues, H., Coelho, A., Nogal, A. B. D. S., de Sousa, A., & Medeiros, R. (2008) · DNA and Cell Biology · doi:10.1089/dna.2008.0744 · Cited by 111 · see citing works

Estrogen receptor and HER2/neu status affect epigenetic differences of tumor-related genes in primary breast tumors

Sunami, E., Shinozaki, M., Sim, M., Nguyen, S. L., Vu, A., Giuliano, A. E., & Hoon, D. S. �. (2008) · Breast Cancer Research · doi:10.1186/bcr2098 · Cited by 111 · see citing works

Cancer metabolites: promising biomarkers for cancer liquid biopsy

Wang, W., Rong, Z., Wang, G., Hou, Y., Yang, F., & Qiu, M. (2023) · Biomarker Research · doi:10.1186/s40364-023-00507-3 · Cited by 108 · see citing works

Metabolomics of human breast cancer: new approaches for tumor typing and biomarker discovery

Denkert, C., Bucher, E., Hilvo, M., Salek, R. M., Orešič, M., Griffin, J. L., Brockmöller, S. F., Klauschen, F., Loibl, S., Barupal, D. K., et al. (2012) · Genome Medicine · doi:10.1186/gm336 · Cited by 101 · see citing works

Human plasma metabolomics for identifying differential metabolites and predicting molecular subtypes of breast cancer

Fan, Y., Zhou, X. Y., Xia, T., Chen, Z., Li, J., Liu, Q., Alolga, R. N., Chen, Y., Lai, M., Li, P., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7155 · Cited by 101 · see citing works

Proteomic profiling of breast cancer metabolism identifies SHMT2 and ASCT2 as prognostic factors

Bernhardt, S., Bayerlová, M., Vetter, M., Wachter, A., Mitra, D., Hanf, V., Lantzsch, T., Uleer, C., Peschel, S., John, J., et al. (2017) · Breast Cancer Research · doi:10.1186/s13058-017-0905-7 · Cited by 101 · see citing works

Radiogenomic analysis reveals tumor heterogeneity of triple-negative breast cancer

Jiang, L., You, C., Xiao, Y., Wang, H., Su, G.-H., Xia, B., Zheng, R., Zhang, D., Jiang, Y., Gu, Y., et al. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100694 · Cited by 101 · see citing works

Adipocyte mesenchymal transition contributes to mammary tumor progression

Zhu, Q., Zhu, Y., Hepler, C., Zhang, Q., Park, J., Gliniak, C. M., Henry, G. H., Crewe, C., Bu, D., Zhang, Z., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111362 · Cited by 99 · see citing works

Single-cell and spatially resolved analysis uncovers cell heterogeneity of breast cancer

Liu, S., Gao, Z., Wu, J., Zheng, H., Li, B., Sun, S., Meng, X., & Wu, Q. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01236-0 · Cited by 98 · see citing works

The Molecular Pathology of Hereditary Breast Cancer

Palacios, J., Robles‐Frías, M. J., Castilla, M. Á., López‐García, M. Á., & Benitez, J. J. (2008) · Pathobiology · doi:10.1159/000123846 · Cited by 95 · see citing works

Non-Invasive Assessment of Breast Cancer Molecular Subtypes with Multiparametric Magnetic Resonance Imaging Radiomics

Leithner, D., Mayerhoefer, M. E., Martinez, D. F., Jochelson, M. S., Morris, E. A., Thakur, S. B., & Pinker, K. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9061853 · Cited by 95 · see citing works

Defining a metabolic landscape of tumours: genome meets metabolism

Nanda, C. S., Venkateswaran, S. V., Patani, N., & Yuneva, M. O. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0663-7 · Cited by 94 · see citing works

Irinotecan-induced mucositis is associated with changes in intestinal mucins

Stringer, A. M., Gibson, R. J., Logan, R. M., Bowen, J. M., Yeoh, A. S. J., Laurence, J., & Keefe, D. M. K. (2008) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-008-0855-y · Cited by 92 · see citing works

Why the Gold Standard Approach by Mammography Demands Extension by Multiomics? Application of Liquid Biopsy miRNA Profiles to Breast Cancer Disease Management

Žúbor, P., Kubatka, P., Kajo, K., Daňková, Z., Poláček, H., Bielik, T., Kúdela, E., Samec, M., Líšková, A., Vlcakova, D., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20122878 · Cited by 91 · see citing works

Personalized medicine in breast cancer: pharmacogenomics approaches

Jeibouei, S., Akbari, M. E., Kalbasi, A., Aref, A. R., Ajoudanian, M., Rezvani, A., & Zali, H. (2019) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s167886 · Cited by 89 · see citing works

Preclinical Evaluation of Fatty Acid Synthase and EGFR Inhibition in Triple-Negative Breast Cancer

Giró‐Perafita, A., Palomeras, S., Lum, D. H., Blancafort, A., Viñas, G., Oliveras, G., Pérez-Bueno, F., Sarrats, A., Welm, A. L., & Puig, T. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-3133 · Cited by 88 · see citing works

Assessing tumor heterogeneity using ctDNA to predict and monitor therapeutic response in metastatic breast cancer

Ma, F., Guan, Y., Yi, Z., Chang, L., Li, Q., Chen, S., Zhu, W., Guan, X., Li, C., Qian, H., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32536 · Cited by 88 · see citing works

Whole Transcriptome RNA-Seq Analysis of Breast Cancer Recurrence Risk Using Formalin-Fixed Paraffin-Embedded Tumor Tissue

Sinicropi, D. V., Qu, K., Collin, F., Crager, M., Liu, M., Pelham, R. J., Pho, M., Rossi, A. D., Jeong, J., Scott, A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040092 · Cited by 82 · see citing works

Lactate and glycine—potential MR biomarkers of prognosis in estrogen receptor‐positive breast cancers

Giskeødegård, G. F., Lundgren, S., Sitter, B., Fjøsne, H. E., Postma, G., Buydens, L. M. C., Gribbestad, I. S., & Bathen, T. F. (2012) · NMR in Biomedicine · doi:10.1002/nbm.2798 · Cited by 81 · see citing works

Omics-Based Investigations of Breast Cancer

Neagu, A.-N., Whitham, D., Bruno, P. S., Morrissiey, H., Darie, C. A., & Darie, C. C. (2023) · Molecules · doi:10.3390/molecules28124768 · Cited by 79 · see citing works

CST6 promoter methylation in circulating cell-free DNA of breast cancer patients

Chimonidou, M., Tzitzira, A., Strati, A. D., Sotiropoulou, G., Sfikas, C., Malamos, N., Georgoulias, V., & Lianidou, E. S. (2012) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2012.09.015 · Cited by 78 · see citing works

Integration of Metabolomics and Expression of Glycerol-3-phosphate Acyltransferase (GPAM) in Breast Cancer—Link to Patient Survival, Hormone Receptor Status, and Metabolic Profiling

Brockmöller, S. F., Bucher, E., Müller, B. M., Budczies, J., Hilvo, M., Griffin, J. L., Orešič, M., Kallioniemi, O., Iljin, K., Loibl, S., et al. (2011) · Journal of Proteome Research · doi:10.1021/pr200685r · Cited by 77 · see citing works

Qualitative Radiogenomics: Association between Oncotype DX Test Recurrence Score and BI-RADS Mammographic and Breast MR Imaging Features

Woodard, G. A., Ray, K. M., Joe, B. N., & Price, E. R. (2017) · Radiology · doi:10.1148/radiol.2017162333 · Cited by 77 · see citing works

Single-cell RNA-seq dissects the intratumoral heterogeneity of triple-negative breast cancer based on gene regulatory networks

Zhou, S., Huang, Y., Liu, H., Zhou, X., Yuan, M., Hou, F., Wang, L., & Jiang, W. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.12.018 · Cited by 77 · see citing works

Untargeted saliva metabonomics study of breast cancer based on ultra performance liquid chromatography coupled to mass spectrometry with HILIC and RPLC separations

Zhong, L., Cheng, F., Lu, X., Duan, Y., & Wang, X. (2016) · Talanta · doi:10.1016/j.talanta.2016.04.049 · Cited by 76 · see citing works

Differences in elongation of very long chain fatty acids and fatty acid metabolism between triple-negative and hormone receptor-positive breast cancer

Yamashita, Y., Nishiumi, S., Kono, S., Takao, S., Azuma, T., & Yoshida, M. (2017) · BMC Cancer · doi:10.1186/s12885-017-3554-4 · Cited by 75 · see citing works

Evaluation of cell-free tumour DNA and RNA in patients with breast cancer and benign breast disease

Schwarzenbach, H., Müller, V., Milde‐Langosch, K., Steinbach, B., & Pantel, K. (2011) · Molecular BioSystems · doi:10.1039/c1mb05197k · Cited by 75 · see citing works

Oncotype DX Breast Recurrence Score®: A Review of its Use in Early-Stage Breast Cancer

Syed, Y. Y. (2020) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-020-00482-7 · Cited by 75 · see citing works

Elevated level of cell-free plasma DNA is associated with breast cancer

Zhong, X. Y., Ladewig, A., Schmid, S. M., Wight, E., Hahn, S., & Holzgreve, W. (2007) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-007-0345-1 · Cited by 72 · see citing works

Radiogenomics of breast cancer using dynamic contrast enhanced MRI and gene expression profiling

Yeh, A. C., Li, H., Zhu, Y., Zhang, J., Khramtsova, G. F., Drukker, K., Edwards, A. V., McGregor, S. M., Yoshimatsu, T. F., Zheng, Y., et al. (2019) · Cancer Imaging · doi:10.1186/s40644-019-0233-5 · Cited by 72 · see citing works

Influence of DNA copy number and mRNA levels on the expression of breast cancer related proteins

Myhre, S., Lingjærde, O. C., Hennessy, B. T., Aure, M. R. R., Carey, M. S., Alsner, J., Tramm, T., Overgaard, J., Mills, G. B., Børresen‐Dale, A., et al. (2013) · Molecular Oncology · doi:10.1016/j.molonc.2013.02.018 · Cited by 71 · see citing works

Epigenetic Regulation in Breast Cancer: Insights on Epidrugs

Kim, A., Mo, K., Kwon, H., Choe, S., Park, M., Kwak, W., & Yoon, H. (2023) · Epigenomes · doi:10.3390/epigenomes7010006 · Cited by 70 · see citing works

Harnessing Epigenetics for Breast Cancer Therapy: The Role of DNA Methylation, Histone Modifications, and MicroRNA

Szczepanek, J., Skorupa, M., Jarkiewicz‐Tretyn, J., Cybulski, C., & Tretyn, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087235 · Cited by 70 · see citing works

Novel insights into breast cancer copy number genetic heterogeneity revealed by single-cell genome sequencing

Baslan, T., Kendall, J., Volyanskyy, K. Y., McNamara, K. L., Cox, H., D'Italia, S., Ambrosio, F. J., Riggs, M. G., Rodgers, L., Leotta, A., et al. (2020) · eLife · doi:10.7554/elife.51480 · Cited by 67 · see citing works

Proteomic patterns associated with response to breast cancer neoadjuvant treatment

Shenoy, A., Nataraj, N. B., Perry, G., Loayza‐Puch, F., Nagel, R., Marin, I., Balint, N., Moshe, N. B. B., Pavlovski, A., Barshack, I., et al. (2020) · Molecular Systems Biology · doi:10.15252/msb.20209443 · Cited by 66 · see citing works

Comparison of frequencies and prognostic effect of molecular subtypes between young and elderly breast cancer patients

de Kruijf, E. M., Bastiaannet, E., Rubertà, F., de Craen, A. J. M., Kuppen, P. J. K., Smit, V. T. H. B. M., van de Velde, C. J. �., & Liefers, G. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.03.022 · Cited by 65 · see citing works

Circulating tumor cells before and during follow-up after breast cancer surgery

van Dalum, G., STAM, G. J. V. D., Tibbe, A. G. J., Franken, B., MASTBOOM, W. J. B., VERMES, I., de Groot, M. R., & Terstappen, L. W. M. M. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2694 · Cited by 65 · see citing works

MammaPrint guides treatment decisions in breast Cancer: results of the IMPACt trial

Soliman, H., Shah, V., Srkalovic, G., Mahtani, R., Levine, E., Mavromatis, B., Srinivasiah, J., Kassar, M., Gabordi, R., Qamar, R., et al. (2020) · BMC Cancer · doi:10.1186/s12885-020-6534-z · Cited by 65 · see citing works

Deciphering metabolic rewiring in breast cancer subtypes

Ogrodzinski, M. P., Bernard, J. J., & Lunt, S. Y. (2017) · Translational research · doi:10.1016/j.trsl.2017.07.004 · Cited by 64 · see citing works

Non-Invasive Tumor Genotyping Using Radiogenomic Biomarkers, a Systematic Review and Oncology-Wide Pathway Analysis

Jansen, R. W., van Amstel, P., Martens, R. M., Kooi, I. E., Wesseling, P., de Langen, A. J., Menke-Van der Houven van Oordt, C. W., Jansen, B. H. E., Moll, A. C., Dorsman, J. C., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.24893 · Cited by 63 · see citing works

A review on recent trends in the phosphoproteomics workflow. From sample preparation to data analysis

Urban, J. (2021) · Analytica Chimica Acta · doi:10.1016/j.aca.2021.338857 · Cited by 63 · see citing works

A two-gene epigenetic signature for the prediction of response to neoadjuvant chemotherapy in triple-negative breast cancer patients

Pineda, B., Díaz‐Lagares, Á., Fidalgo, J. A. P., Burgués, O., González‐Barrallo, I., Crujeiras, A. B., Sandoval, J., Esteller, M., Lluch, A. M., & Eroles, P. (2019) · Clinical Epigenetics · doi:10.1186/s13148-019-0626-0 · Cited by 60 · see citing works

Free Circulating Tumor DNA as a Diagnostic Marker for Breast Cancer

Hashad, D. I., Sorour, A., Ghazal, A. A. E. R., & Talaat, I. M. (2012) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.21548 · Cited by 59 · see citing works

Ultrasound-Based Radiomics Analysis for Predicting Disease-Free Survival of Invasive Breast Cancer

Xiong, L., Chen, H., Tang, X., Chen, B., Jiang, X., Liu, L., Feng, Y., Liu, L., & Li, L. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.621993 · Cited by 57 · see citing works

Metabolomics of Breast Cancer: A Review

Subramani, R., Poudel, S., Smith, K. D., Estrada, A., & Lakshmanaswamy, R. (2022) · Metabolites · doi:10.3390/metabo12070643 · Cited by 56 · see citing works

Prediction of Recurrence and Survival for Triple-Negative Breast Cancer (TNBC) by a Protein Signature in Tissue Samples

Campone, M., Valo, I., Jézéquel, P., Moreau, M., Boissard, A., Campion, L., Loussouarn, D., Verrièle, V., Coqueret, O., & Guette, C. (2015) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m115.048967 · Cited by 56 · see citing works

The role of the bacterial microbiome in the treatment of cancer

Yu, Z., Xie, R., You, R., Liu, Y., Chen, X.-Y., Chen, M., & Huang, P.-Y. (2021) · BMC Cancer · doi:10.1186/s12885-021-08664-0 · Cited by 56 · see citing works

Radiomic differentiation of breast cancer molecular subtypes using pre-operative breast imaging – A systematic review and meta-analysis

Davey, M. G., Davey, M. S., Boland, M. R., Ryan, É. J., Lowery, A., & Kerin, M. J. (2021) · European Journal of Radiology · doi:10.1016/j.ejrad.2021.109996 · Cited by 56 · see citing works

Metabolic fingerprinting in breast cancer stages through 1H NMR spectroscopy-based metabolomic analysis of plasma

Suman, S., Sharma, R. K., Kumar, V., Sinha, N., & Shukla, Y. (2018) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2018.07.024 · Cited by 53 · see citing works

Predictive biomarkers and potential drug combinations of epi-drugs in cancer therapy

Yang, T., Yang, Y., & Wang, Y. (2021) · Clinical Epigenetics · doi:10.1186/s13148-021-01098-2 · Cited by 53 · see citing works

The role of clonal communication and heterogeneity in breast cancer

Martín-Pardillos, A., Valls‐Chiva, A., Vargas, G. B., Hurtado, P., Piñeiro, R., Guijarro-Carrillo, P. J., Hümmer, S., Serrano, E., Rodríguez‐Casanova, A., Díaz‐Lagares, Á., et al. (2019) · BMC Cancer · doi:10.1186/s12885-019-5883-y · Cited by 52 · see citing works

Mapping Breast Cancer Microenvironment Through Single-Cell Omics

Tan, Z., Chen, K., Sun, M., Yang, F., Wong, M., Wang, S., & Zheng, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.868813 · Cited by 52 · see citing works

Risk factors for anthracycline-associated cardiotoxicity

Reinbolt, R. E., Patel, R., Pan, X. J., Timmers, C. D., Pilarski, R., Shapiro, C. L., & Lustberg, M. B. (2015) · Supportive Care in Cancer · doi:10.1007/s00520-015-3008-y · Cited by 50 · see citing works

Multi-omics dataset to decipher the complexity of drug resistance in diffuse large B-cell lymphoma

Fornecker, L., Muller, L., Bertrand, F., Paul, N., Pichot, A., Herbrecht, R., Chenard, M., Mauvieux, L., Vallat, L. D., Bahram, S., et al. (2019) · Scientific Reports · doi:10.1038/s41598-018-37273-4 · Cited by 48 · see citing works

Estrogen Receptor Mutations in Breast Cancer—New Focus on an Old Target

Segal, C. V., & Dowsett, M. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0067 · Cited by 48 · see citing works

Paclitaxel-induced sensory peripheral neuropathy is associated with an ABCB1 single nucleotide polymorphism and older age in Japanese

Tanabe, Y., Shimizu, C., Hamada, A., Hashimoto, K., Ikeda, K., Nishizawa, D., Hasegawa, J., Shimomura, A., Ozaki, Y., Tamura, N., et al. (2017) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-017-3314-9 · Cited by 48 · see citing works

Sample preparation strategies for targeted proteomics via proteotypic peptides in human blood using liquid chromatography tandem mass spectrometry

Dittrich, J., Becker, S., Hecht, M., & Ceglarek, U. (2014) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201400121 · Cited by 47 · see citing works

Integrated Transcriptome and Pathway Analyses Revealed Multiple Activated Pathways in Breast Cancer

Vishnubalaji, R., Nair, V. S., Ouararhni, K., Elkord, E., & Alajez, N. M. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00910 · Cited by 46 · see citing works

Genetic heterogeneity beyond CYP2C8*3 does not explain differential sensitivity to paclitaxel-induced neuropathy

Hertz, D. L., Roy, S., Jack, J., Motsinger‐Reif, A. A., Drobish, A. A., Clark, L. S., Carey, L., Dees, E. C., & McLeod, H. L. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-2910-1 · Cited by 44 · see citing works

The Epigenomic Revolution in Breast Cancer

Dávalos, V., Martínez‐Cardús, A., & Esteller, M. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2017.07.002 · Cited by 43 · see citing works

Tumor-related Microbiome in the Breast Microenvironment and Breast Cancer

Wang, N., Sun, T., & Xu, J. (2021) · Journal of Cancer · doi:10.7150/jca.58986 · Cited by 42 · see citing works

Transient commensal clonal interactions can drive tumor metastasis

Amara, S. N.-A., Kuiken, H. J., Selfors, L. M., Butler, T. M., Leung, M. L., Leung, C. T., Kuhn, E. P., Kolarova, T. R., Hage, C., Ganesh, K. S., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19584-1 · Cited by 40 · see citing works

Identification of Metabolic Alterations in Breast Cancer Using Mass Spectrometry-Based Metabolomic Analysis

Fan, S., Shahid, M., Jin, P., Asher, A., & Kim, J. (2020) · Metabolites · doi:10.3390/metabo10040170 · Cited by 40 · see citing works

Digital breast tomosynthesis: Image acquisition principles and artifacts

Sujlana, P., Mahesh, M., Vedantham, S., Harvey, S. C., Mullen, L. A., & Woods, R. W. (2018) · Clinical Imaging · doi:10.1016/j.clinimag.2018.07.013 · Cited by 39 · see citing works

Natural Bioactive Compounds Targeting Histone Deacetylases in Human Cancers: Recent Updates

Bouyahya, A., Hachlafi, N. E., Aanniz, T., Bourais, I., Mechchate, H., Benali, T., Shariati, M. A., Burkov, P., Lorenzo, J. M., Wilairatana, P., et al. (2022) · Molecules · doi:10.3390/molecules27082568 · Cited by 38 · see citing works

Single-Cell Transcriptome Profiling Reveals Intratumoral Heterogeneity and Molecular Features of Ductal Carcinoma In Situ

Tokura, M., Nakayama, J., Prieto‐Vila, M., Shiino, S., Yoshida, M., Yamamoto, T., Watanabe, N., Takayama, S., Suzuki, Y., Okamoto, K., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-22-0090 · Cited by 38 · see citing works

Personalized medicine in breast cancer: pharmacogenomics approaches

Jeibouei, S., Akbari, M. E., Kalbasi, A., Aref, A. R., Ajoudanian, M., Rezvani, A., & Zali, H. (2019) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 35 · see citing works

Personalized medicine in breast cancer: pharmacogenomics approaches

Jeibouei, S., Akbari, M. E., Kalbasi, A., Aref, A. R., Ajoudanian, M., Rezvani, A., & Zali, H. (2019) · Dove Medical Press (Taylor and Francis Group) · Cited by 35 · see citing works

Alternative polyadenylation of single cells delineates cell types and serves as a prognostic marker in early stage breast cancer

Kim, N., Chung, W., Eum, H. H., Lee, H., & Park, W. (2019) · PLoS ONE · doi:10.1371/journal.pone.0217196 · Cited by 34 · see citing works

NMR-Based Metabolomics Analysis Predicts Response to Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer

He, X., Gu, J., Zou, D., Yang, H., Zhang, Y., Ding, Y., & Teng, L. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.708052 · Cited by 34 · see citing works

A Radiogenomic Approach for Decoding Molecular Mechanisms Underlying Tumor Progression in Prostate Cancer

Fischer, S., Tahoun, M., Klaan, B., Thierfelder, K. M., Weber, M. D., Krause, B. J., Hakenberg, O. W., Fuellen, G., & Hamed, M. (2019) · Cancers · doi:10.3390/cancers11091293 · Cited by 33 · see citing works

Recent advances of transcriptomics and proteomics in triple‐negative breast cancer prognosis assessment

Li, Y., Kong, X., Wang, Z., & Xuan, L. (2022) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17124 · Cited by 32 · see citing works

SNiPER: a novel hypermethylation biomarker panel for liquid biopsy based early breast cancer detection

Mijnes, J., Tiedemann, J., Eschenbruch, J., Gasthaus, J., Bringezu, S., Bauerschlag, D., Maass, N., Arnold, N., Weimer, J. P., Anzeneder, T., et al. (2019) · Oncotarget · doi:10.18632/oncotarget.27303 · Cited by 32 · see citing works

The 3′UTR signature defines a highly metastatic subgroup of triple-negative breast cancer

Wang, L., Hu, X., Wang, P., & Shao, Z. (2016) · Oncotarget · doi:10.18632/oncotarget.10975 · Cited by 31 · see citing works

Transcriptomic Analysis of Breast Cancer Patients Sensitive and Resistant to Chemotherapy: Looking for Overall Survival and Drug Resistance Biomarkers

Barrón-Gallardo, C. A., García‐Chagollán, M., Morán-Mendoza, A. J., Delgadillo-Cristerna, R., Martínez-Silva, M. G., Aguilar‐Lemarroy, A., & Jave‐Suárez, L. F. (2022) · Technology in Cancer Research & Treatment · doi:10.1177/15330338211068965 · Cited by 30 · see citing works

Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells

Tong, M., Deng, Z., Yang, M., Xu, C., Zhang, X., Zhang, Q., Liao, Y., Deng, X., Lv, D., Zhang, X., et al. (2018) · 癌症：英文版 · doi:10.1186/s40880-018-0326-8 · Cited by 25 · see citing works

Integrative Radiogenomics Approach for Risk Assessment of Post-Operative Metastasis in Pathological T1 Renal Cell Carcinoma: A Pilot Retrospective Cohort Study

Lee, H. W., Cho, H.-H., Joung, J., Jeon, H. G., Jeong, B. C., Jeon, S. S., Lee, H. M., Nam, D., Park, W., Kim, C. K., et al. (2020) · Cancers · doi:10.3390/cancers12040866 · Cited by 25 · see citing works

Phosphoproteomic Analysis of Breast Cancer-Derived Small Extracellular Vesicles Reveals Disease-Specific Phosphorylated Enzymes

Minić, Z., Hüttmann, N., Poolsup, S., Li, Y., Susevski, V., Zaripov, E. A., & Berezovski, M. V. (2022) · Biomedicines · doi:10.3390/biomedicines10020408 · Cited by 25 · see citing works

Proteomics-Based Identification of Dysregulated Proteins and Biomarker Discovery in Invasive Ductal Carcinoma, the Most Common Breast Cancer Subtype

Neagu, A.-N., Whitham, D., Seymour, L., Haaker, N., Pelkey, I., & Darie, C. C. (2023) · Proteomes · doi:10.3390/proteomes11020013 · Cited by 25 · see citing works

Multianalyte liquid biopsy to aid the diagnostic workup of breast cancer

Setayesh, S. M., Hart, O., Naghdloo, A., Higa, N., Nieva, J. J., Lu, J. M., Hwang, S. E., Wilkinson, K., Kidd, M., Anderson, A. K. L., et al. (2022) · npj Breast Cancer · doi:10.1038/s41523-022-00480-4 · Cited by 24 · see citing works

Epigenetic study of early breast cancer (EBC) based on DNA methylation and gene integration analysis

Zhang, W., Wang, H., Qi, Y., Li, S., & Geng, C. (2022) · Scientific Reports · doi:10.1038/s41598-022-05486-3 · Cited by 24 · see citing works

Characterization of metabolic profile of intact non-tumor and tumor breast cells by high-resolution magic angle spinning nuclear magnetic resonance spectroscopy

Maria, R. M., Altei, W. F., Andricopulo, A. D., Becceneri, A. B., Cominetti, M. R., Venâncio, T., & Colnago, L. A. (2015) · Analytical Biochemistry · doi:10.1016/j.ab.2015.07.015 · Cited by 23 · see citing works

‘Breast Cancer Resistance Likelihood and Personalized Treatment Through Integrated Multiomics’

Mehmood, S., Faheem, M. Q., Ismail, H., Farhat, S. M., Ali, M., Younis, S., & Asghar, M. N. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.783494 · Cited by 22 · see citing works

Value of genomics- and radiomics-based machine learning models in the identification of breast cancer molecular subtypes: a systematic review and meta-analysis

Zhang, Y., Li, G., Bian, W., Bai, Y., He, S., Liu, Y., Liu, H., & Liu, J. (2022) · Annals of Translational Medicine · doi:10.21037/atm-22-5986 · Cited by 22 · see citing works

Integration of multi-omics data reveals a novel hybrid breast cancer subtype and its biomarkers

Wang, Z., Li, X., Wen, X.-L., Wang, N., Guo, Y., Xu, Z., Fu, S.-H., Xiong, F.-F., Bai, J., Gao, X., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1130092 · Cited by 21 · see citing works

Role of MRI in screening, diagnosis and management of breast cancer

Swayampakula, A. K., Dillis, C., & Abraham, J. (2008) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.8.5.811 · Cited by 20 · see citing works

Integrated analysis of differentially expressed genes and pathways in triple-negative breast cancer

Peng, C., Ma, W., Xia, W., & Zheng, W. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6101 · Cited by 20 · see citing works

NSD3: Advances in cancer therapeutic potential and inhibitors research

Xiu, S., Chi, X., Jia, Z., Cheng, S., Zhang, X., Li, Q., Gao, T., Zhang, L., & Liu, Z. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115440 · Cited by 18 · see citing works

Assessment of DNA methylation profiling and copy number variation as indications of clonal relationship in ipsilateral and contralateral breast cancers to distinguish recurrent breast cancer from a second primary tumour

Huang, K. T., Mikeska, T., Li, J., Takano, E. A., Millar, E. K. A., Graham, P., Boyle, S. E., Campbell, I., Speed, T. P., Dobrovic, A., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-1676-0 · Cited by 17 · see citing works

Differential phosphopeptide expression in a benign breast tissue, and triple-negative primary and metastatic breast cancer tissues from the same African-American woman by LC-LTQ/FT-ICR mass spectrometry

Semaan, S. M., Wang, X., Stewart, P. A., Marshall, A. G., & Sang, Q. A. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.07.057 · Cited by 17 · see citing works

An magnetic resonance-based plasma metabonomic investigation on abnormal Savda in different complicated diseases

Mamtimin, B., Hizbulla, M., Kurbantay, N., You, L., Xinghai, Y., & Upur, H. (2014) · 中医杂志：英文版 · doi:10.1016/s0254-6272(14)60073-x · Cited by 17 · see citing works

Drug Metabolism for the Identification of Clinical Biomarkers in Breast Cancer

Costa, B., & Vale, N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063181 · Cited by 16 · see citing works

A genome-wide cell-free DNA methylation analysis identifies an episignature associated with metastatic luminal B breast cancer

Rodríguez‐Casanova, A., Costa‐Fraga, N., Carballeira, C. C., González-Conde, M., Abuín, C., Bao‐Caamano, A., García‐Caballero, T., Brozos-Vázquez, E., Rodríguez-López, C., Cebey-López, V., et al. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1016955 · Cited by 15 · see citing works

Phosphoproteomic analysis of neoadjuvant breast cancer suggests that increased sensitivity to paclitaxel is driven by CDK4 and filamin A

Mouron, S. A., Bueno, M. J., Lluch, A. M., Manso, L., Calvo, I., Cortés, J., García-Sáenz, J. Á., Gil‐Gil, M., Martínez-Jáñez, N., Apala, J. V., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-35065-z · Cited by 14 · see citing works

Effects of sulforaphane on breast cancer based on metabolome and microbiome

Cao, S., Hu, S., Jiang, P., Zhang, Z., Li, L., & Wu, Q. (2023) · Food Science & Nutrition · doi:10.1002/fsn3.3168 · Cited by 14 · see citing works

Are Estrogen Receptor Genomic Aberrations Predictive of Hormone Therapy Response in Breast Cancer?

Tabarestani, S., Motallebi, M., & Akbari, M. E. (2016) · Iranian Journal of Cancer Prevention · doi:10.17795/ijcp-6565 · Cited by 13 · see citing works

Diversity and heterogeneity in human breast cancer adipose tissue revealed at single-nucleus resolution

Tang, L., Li, T., Xie, J., Huo, Y., & Ye, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1158027 · Cited by 13 · see citing works

Response to W.C. Taylor, and C. Fiala and E.P. Diamandis

Liu, M., Oxnard, G. R., Klein, E. A., Swanton, C., & Seiden, M. V. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.06.008 · Cited by 13 · see citing works

Spatially Annotated Single Cell Sequencing for Unraveling Intratumor Heterogeneity

Smit, M. M., Feller, K. J., You, L., Storteboom, J., Begce, Y., Beerens, C. E. M. T., & Chien, M. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.829509 · Cited by 12 · see citing works

Application of intravoxel incoherent motion diffusion-weighted imaging in differential diagnosis and molecular subtype analysis of breast cancer.

Ma, Y., Shan, D.-D., Wei, J., & Chen, A. (2021) · PubMed Central · Cited by 11 · see citing works

Multi-omics inference of differential breast cancer-related transcriptional regulatory network gene hubs between young Black and White patients

Aguilar, B. H., Abdilleh, K., & Acquaah-Mensah, G. K. (2022) · Cancer Genetics · doi:10.1016/j.cancergen.2022.11.001 · Cited by 10 · see citing works

Combination strategies to target metabolic flexibility in cancer

Krstić, J., Schindlmaier, K., & Prokesch, A. (2022) · International review of cytology · doi:10.1016/bs.ircmb.2022.03.001 · Cited by 9 · see citing works

Comparison of serum metabolomics in women with breast Cancer Prior to Chemotherapy and at 1 year: cardiometabolic implications

Lyon, D., Yao, Y., Garrett, T. J., Kelly, D. L., Cousin, L., & Archer, K. J. (2023) · BMC Women s Health · doi:10.1186/s12905-023-02355-7 · Cited by 8 · see citing works

Proportion of phage-insensitive and phage-sensitive cells within pure strains of lactic streptococci, and the influence of calcium

Tesfaigzi, Y., & Süßmuth, R. (1989) · Journal of Dairy Research · doi:10.1017/s0022029900026327 · Cited by 3 · see citing works

Epithelial–Mesenchymal Transition in Cancer: Insights Into Therapeutic Targets and Clinical Implications

Srinivasan, D., Balakrishnan, R., Chauhan, A., Kumar, J., Girija, D. M., Shrestha, R., Shrestha, R., & Subbarayan, R. (2025) · MedComm · doi:10.1002/mco2.70333 · Cited by 38 · see citing works

Editorial: Heterogeneity in breast cancer: clinical and therapeutic implications

Carlino, F., Solinas, C., Orditura, M., Bisceglia, M. D., Pellegrino, B., & Diana, A. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1321654 · Cited by 24 · see citing works

Comparative analysis of statistical and deep learning-based multi-omics integration for breast cancer subtype classification

Omran, M. M., Emam, M., Gamaleldin, M., Abushady, A. M., Elattar, M., & El-Hadidi, M. S. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06662-5 · Cited by 22 · see citing works

ELW‐CNN: An extremely lightweight convolutional neural network for enhancing interoperability in colon and lung cancer identification using explainable AI

Opee, S. A., Eva, A. A., Noor, A., Hasan, S. M., & Mridha, M. F. (2025) · Healthcare Technology Letters · doi:10.1049/htl2.12122 · Cited by 20 · see citing works

Revisiting Epigenetics Fundamentals and Its Biomedical Implications

Meza-Menchaca, T., Albores-Medina, A., Heredia-Mendez, A. J., Ruíz-May, E., Ricaño-Rodríguez, J., Gallegos-García, V., Esquivel, A., Vettoretti-Maldonado, G., & Campos-Parra, A. D. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147927 · Cited by 15 · see citing works

Artificial intelligence and multi-omics convergence in breast cancer: Revolutionizing diagnosis, prognostication, and precision oncology

Jiang, B., Wu, Y., Chen, X., Jian, C., & Wang, W. (2026) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2026.105160 · Cited by 13 · see citing works

Emerging Breast Cancer Subpopulations: Functional Heterogeneity Beyond the Classical Subtypes

Kotsifaki, A., Kalouda, G., Karalexis, E., Stathaki, M., Μεταξάς, Γ., & Armakolas, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262311599 · Cited by 12 · see citing works

Zebrafish navigating the metabolic maze: insights into human disease – assets, challenges and future implications

Yashaswini, C., Kiran, N. S., & Chatterjee, A. (2024) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-024-01539-8 · Cited by 12 · see citing works

Analytical strategies in early breast cancer diagnostic biomarker discovery by machine learning methods: Promises, advances and outlooks

Naghib, S. M., Khorasani, M. A., Sharifianjazi, F., & Tavamaishvili, K. (2025) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2025.118412 · Cited by 11 · see citing works

Exploring novel protein-based biomarkers for advancing breast cancer diagnosis: A review

Vellan, C. J., Islam, T., Silva, S. D., Taib, N. A. M., Prasanna, G., & Jayapalan, J. J. (2024) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2024.110776 · Cited by 11 · see citing works

Technological Innovations and Multi-Omics Approaches in Cancer Research: A Comprehensive Review

Velmurugan, S., Wankhar, D., Paramasivan, V., & Subbaraj, G. K. (2025) · Biocell · doi:10.32604/biocell.2025.065891 · Cited by 10 · see citing works

Mechanisms of traditional Chinese medicine overcoming of radiotherapy resistance in breast cancer

Zhao, X., Luo, T., Qiu, Y., Yang, Z., Wang, D., Wang, Z., Zeng, J., & Bi, Z. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1388750 · Cited by 9 · see citing works

Metabolite Predictors of Breast and Colorectal Cancer Risk in the Women’s Health Initiative

Navarro, S. L., Williamson, B. D., Huang, Y., Gowda, G. A. N., Raftery, D., Tinker, L. F., Zheng, C., Beresford, S. A. A., Purcell, H. J., Djukovic, D., et al. (2024) · Metabolites · doi:10.3390/metabo14080463 · Cited by 8 · see citing works

Distinct mRNA expression profiles and miRNA regulators of the PI3K/AKT/mTOR pathway in breast cancer: insights into tumor progression and therapeutic targets

Sirek, T., Król-Jatręga, K., Borawski, P., Zmarzły, N., Boroń, D., Ossowski, P., Nowotny-Czupryna, O., Boroń, K., Janiszewska-Bil, D., Mitka-Krysiak, E., et al. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2024.1515387 · Cited by 8 · see citing works

Precision Medicine for Cancer and Health Equity in Latin America: Generating Understanding for Policy and Health System Shaping

González, A. R., Acuña-Merchán, L. A., Alexander, J. A. A., Kaen, D., López-Correa, C., Martin, C. M., Attwill, A., Marinetti, T., Rocha, J. V., & Barrios, C. H. (2025) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph22081220 · Cited by 8 · see citing works

Metabolomics Biomarkers for Breast Cancer: An updated perspective

Vellan, C. J., Natesan, V., & Jayapalan, J. J. (2025) · Clinical Breast Cancer · doi:10.1016/j.clbc.2025.05.005 · Cited by 6 · see citing works

Liquid biopsy in breast cancer management: From circulating biomarkers to clinical breakthroughs

Taki, ‎. G., Shareef, A., Baldaniya, L., Oweis, R. J., Jyothi, S. R., Singh, U., Sahoo, S., Chauhan, A. S., Khazratov, A., Sameer, H. N., et al. (2025) · Journal of Investigative Medicine · doi:10.1177/10815589251366905 · Cited by 5 · see citing works

Lactate Ameliorates Kainic Acid-Induced Neuroinflammation and Cognitive Impairment via the Chemokine Signaling Pathway in Mice

Chu, X., Ge, Y., Geng, C., Cao, P., Wei, P., Fu, B., Deng, Z., Li, Y., & Zhao, G. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s498738 · Cited by 5 · see citing works

Innovative Approaches to EMT-Related Biomarker Identification in Breast Cancer: Multi-Omics and Machine Learning Methods

Khalili‐Tanha, G., & Shoari, A. (2025) · BioTech · doi:10.3390/biotech14030075 · Cited by 4 · see citing works

Upregulation of EPSTI1/Drp1/AKT1 Signaling Pathways Using pDNA/Melittin Against Breast Cancer

Khorsand-Dehkordi, S., & Doosti, A. (2024) · Biochemical Genetics · doi:10.1007/s10528-024-10806-5 · Cited by 4 · see citing works

MicroRNAs: From Bench to Bedside Applications as Breast Cancer Therapeutics

Samad, M. A., Ahmad, I., Asghar, M. N., Suhail, M., Rehan, M., Al-Abbasi, F. A., Alsolami, K., Akhter, M. S., Ahmad, A., & Tabrez, S. (2025) · Seminars in Oncology · doi:10.1016/j.seminoncol.2025.152386 · Cited by 4 · see citing works

An uncertainty-aware dynamic decision framework for progressive multi-omics integration in classification tasks

Mu, N., Yang, H., & Chen, Z. (2025) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2025.109179 · Cited by 4 · see citing works

COL1A1, COL1A2, CHN1, and FN1 Promote Tumorogenesis and Act as Markers of Diagnosis and Survival in Gastric Cancer Patients

Yan, Y., Li, Y.-B., Liang, H., Chen, D., Li, B., & Murshed, A. (2025) · Current Pharmaceutical Biotechnology · doi:10.2174/0113892010332329241119104430 · Cited by 4 · see citing works

Proteomics signatures of human breast cancer: A systematic review

García‐Chico, C., Plaza‐Florido, A., López‐Ortiz, S., Pinto-Fraga, J., Maroto‐Izquierdo, S., Khoramipour, K., Sagarra‐Romero, L., Carmen-Fiuza-Luces, Lucía, A., & Santos‐Lozano, A. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104950 · Cited by 3 · see citing works

Recent advancements in artificial intelligence - driven breast cancer molecular subtypes classification using multi-omics: A comprehensive review

Shah, S., Samah, A. A., Madni, S. H. H., Hashim, S. Z. M., & Faheem, M. (2026) · Engineering Applications of Artificial Intelligence · doi:10.1016/j.engappai.2026.114237 · Cited by 3 · see citing works

Contemplating the prognostic and therapeutic potential of CD19: a comprehensive analysis across diverse cancer types

Yang, X. (2024) · American Journal of Translational Research · doi:10.62347/kjgs9928 · Cited by 2 · see citing works

Advancements in Multi-omics Integration for Comprehensive Cancer Understanding and Treatment

Thapliyal, A. P., Singh, P., Pant, M., & Pant, K. (2025) · Advances in Science, Technology & Innovation/Advances in science, technology & innovation · doi:10.1007/978-3-031-80973-6_16 · Cited by 2 · see citing works

A review on understanding chemobrain and neuroprotection effects on breast cancer therapies on cognitive function

Prabhu, N., Vijayan, V., & Mythili, N. (2025) · Discover Applied Sciences · doi:10.1007/s42452-025-07919-w · Cited by 2 · see citing works

P3DE: A novel integration of deep ensemble learning and parameter-less optimization for superior breast cancer biomarker discovery

Rakhshaninejad, M., Fathian, M., Shirkoohi, R., Barzinpour, F., & Gandomi, A. H. (2026) · Neural Computing and Applications · doi:10.1007/s00521-026-11896-5 · Cited by 2 · see citing works

Non-Invasive Diagnosis of Early Breast Cancer: Current and Emerging Liquid Biopsy Biomarkers

Kotsifaki, A., Masoura, C.-R., Limogianni, G., Kalouda, G., Stathaki, M., & Armakolas, A. (2026) · Cancers · doi:10.3390/cancers18142344 · Cited by 2 · see citing works

Importance of LINC00852/miR-145-5p in breast cancer: a bioinformatics and experimental study

Shakoori, A., Hosseinzadeh, A., Nafisi, N., Omranipour, R., Sahebi, L., Hosseinkhan, N., Ahmadi, M., Ghafouri‐Fard, S., & Abtin, M. (2024) · Discover Oncology · doi:10.1007/s12672-024-01553-5 · Cited by 2 · see citing works

Biomedical image characterization and radio genomics using machine learning techniques

Okunlola, F. O., Adetuyi, T. G., Olajide, P. A., Okunlola, A. R., Adetuyi, B. O., Adeyemo-Eleyode, V. O., Akomolafe, A. A., Yunana, N., Baba, F., Nwachukwu, K. C., et al. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15452-2.00019-4 · Cited by 2 · see citing works

Metabolomics and Cancer: Identification of Biomarkers from Plant-Based Pharmaceuticals Using an Integrated Approach

Manickavasagam, G., Mahendran, T. R., & Lim, V. (2024) · Interdisciplinary cancer research · doi:10.1007/16833_2024_223 · Cited by 2 · see citing works

AET-net: A framework for subtype classification based on the multi-omics data of breast cancer

Zhang, Q. E., Wei, Y., Hou, J., Xu, J., Sun, Z., Zhang, H., & Zhong, Z. (2024) · Molecular & cellular biomechanics · doi:10.62617/mcb785 · Cited by 1 · see citing works

Nanomaterials in Personalized Medicine: Pioneering Precision Strategies for Cancer Prevention

Umer, M. F., & Arshed, M. (2025) · Springer eBooks · doi:10.1007/978-981-97-9827-8_20 · Cited by 1 · see citing works

Evaluation of Machine Learning Models for Breast Cancer Detection in Microarray Gene Expression Profiles

Abdullah, M., & Wah, Y. B. (2024) · Lecture notes on data engineering and communications technologies · doi:10.1007/978-981-97-0293-0_40 · Cited by 1 · see citing works

OMICS: A NEW VISION FOR BREAST CANCER TREATMENT

Salvatierra, A., Díaz-Baena, D., Guven, O., & Ruiz-Serrano, E. (2023) · Journal of Basic and Applied Genetics · doi:10.35407/bag.2023.34.02.04

Nano-Shields: Transforming Infectious Disease Prevention and Vaccination with Cutting-Edge Nanomaterials

Umer, M. F., & Arshed, M. (2025) · Springer eBooks · doi:10.1007/978-981-97-9827-8_19

Bioinformatics and Computational Biology: Tools for the Genomic Era

Saad, M. H. K., Hadi, M. M., Zaghir, A. H., Zidane, Z. M., & Sadk, M. A. (2025) · Bright Sky Publications eBooks · doi:10.62906/bs.book.366

Topological Machine Learning: Integrating Topological Data Analysis with Machine Learning to Enhance Breast Cancer Classification

Netshifhire, R., & Visaya, M. V. (2024) · International Conference on Sustainable Technology and Engineering (i-COSTE) · doi:10.1109/i-coste63786.2024.11024568

Disorders of Gut Microbiota and Plasma Metabolic Profiles May Be Associated with Lymph Node Tuberculosis

Long, Y., Huang, J., Zheng, S., Bai, S., Liu, Z., Li, X., Gao, W., Ke, X., Tang, Y., Yang, L., et al. (2025) · Microorganisms · doi:10.3390/microorganisms13071456

Engineering Cures: The Role of 3D Printing in Modern Medicine

Kadiri, S. K., Darshan Gowda, B. S., Khobragade, D. S., & Tiwari, P. K. (2025) · Recent Patents on Engineering · doi:10.2174/0118722121385216250701164448

Molecular Symphony in Breast Cancer: Insights on Genomic Discoveries and Epigenetic Regulation

Thombre, K. R., Gupta, K. R., & Umekar, M. J. (2025) · Current pharmacogenomics and personalized medicine (Online)/Current pharmacogenomics and personalized medicine · doi:10.2174/0118756921389643250731042712

Integrating multiomics data for personalized TNBC management

Bhamre, U. G., Kothawade, H., Bhandari, D. D., Amrutkar, S. V., & Shinkar, D. M. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33565-5.00002-5

The potential for epigenetic-based therapies in breast cancer

Gill, K., Chatterjee, M., Jan, A., & Mir, M. A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-27801-3.00022-3

Breast cancer diagnosis: an overview of cellular, molecular, and genetic testing techniques

Patil, P. C., Kaleem, M., Mujtaba, M. A., Alhosin, M., & Abdurrazzaque, B. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-33347-7.00010-5

Garlic and breast cancer: how far has the research come?

Giampieri, F., Díaz, Y. A., Cassotta, M., & Battino, M. A. (2026) · Phytochemistry Reviews · doi:10.1007/s11101-026-10223-z

Shaping breast cancer progression in obesity: Insights from advanced models and omics tools

Emma, R., Sergi, V., Scordamaglia, D., Scollo, P., Clarke, R. B., Malaguarnera, R., & Francesco, E. M. D. (2026) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2026.189625

Multi-omics and molecular biomarkers in breast cancer: a comprehensive review of diagnostic, prognostic, and predictive applications

Bagheri, K., Saberi, A., Zand, M., & Mahmoudi, A. A. (2026) · Cancer Treatment and Research Communications · doi:10.1016/j.ctarc.2026.101454

GPCR signaling systems facilitate precision interventions for multi-oncology therapy

Pozo, A. D., Pardo, M., Boeringer, T., Craig, C. J., Sorathia, R., Millican, M., & Maudsley, S. R. (2026) · Frontiers in Systems Biology · doi:10.3389/fsysb.2026.1940022

Omics-Nano-CRISPR Strategies for Combating Breast Cancer in the AI Age

Sah, A. K., Patel, S., Kumar, D. R. P., Mishra, P. S., Sisodiya, S., Kumar, A., & Elshaikh, R. H. (2026) · IGI Global eBooks · doi:10.4018/979-8-3373-9715-3.ch006

Omics-Based Investigations of Breast Cancer

Neagu, A.-N., Whitham, D., Bruno, P. S., Morrissiey, H., Darie, C. A., & Darie, C. C. (2023) · Molecules · doi:10.3390/molecules28124768 · Cited by 79 · see citing works

Omics Technologies Applied in Breast Cancer Research

Panal-Cusati, M., de la Muela, M. H., & Zapardiel, I. (2014) · Springer eBooks · doi:10.1007/978-81-322-0843-3_1

Advancing precision and personalized breast cancer treatment through multi-omics technologies

Zhang, C. (2024) · American Journal of Cancer Research · doi:10.62347/mwnz5609 · Cited by 34 · see citing works

‘Omics Approaches in Breast Cancer Research and Clinical Practice

Croft, P. K., Al‐Ejeh, F., Reed, A. E. M., Saunus, J. M., & Lakhani, S. R. (2016) · Advances in Anatomic Pathology · doi:10.1097/pap.0000000000000128 · Cited by 18 · see citing works

Omics Approaches in Breast Cancer : Towards Next-Generation Diagnosis, Prognosis and Therapy

(2014) · Thammasat University Digital Collections